Medicare pressured to cover Alzheimer’s treatments by Bipartisan Group of Attorneys General
26 attorneys general from both political parties urged Medicare to change its contentious policy that restricts coverage to participants in clinical trials and to cover antibody-based Alzheimer's medications like Eisai and Biogen's Leqembi…